MAMMÔ 2026 Day 1 Highlights: From Early Detection and Precision Diagnostics to Treatment De-escalation and Global Breast Cancer Care
Oct 09, 2026
View online
MAMMÔ 2026 Day 1 Highlights: From Early Detection and Precision Diagnostics to Treatment De-escalation and Global Breast Cancer Care
FDA Approved Atezolizumab Plus Chemotherapy for Stage III dMMR Colon Cancer
Tempus AI Expands Collaboration with Merck and Moderna on Individualized Neoantigen Therapy
Arasb Ahmadian Named Candidate for UICC Board of Directors 2026–2028
Who Shaped Oncology in the First Half of 2026: Breaking Down Approvals by Indications
Drew Moghanaki: Can CTV Omission Improve Survival in Limited – Stage SCLC?
GCOS 2026 First Half of Day 2: Precision Exercise, Global Survivorship and New Approaches to Amyloidosis
Lung Cancer Canada Breathe Forward Award: $200,000 for NSCLC Diagnostic Innovation
NCI Office of Data Sharing Impact Prize: $200,000 for Cancer Research Data-Sharing Innovation
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
